ARDITEX Trademark

Trademark Overview


On Monday, January 29, 2024, a trademark application was filed for ARDITEX with the United States Patent and Trademark Office. The USPTO has given the ARDITEX trademark a serial number of 98380725. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 24, 2024. This trademark is owned by China Medical University. The ARDITEX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Collection and systematization of information into computer databases in the medical and clinical fields.
arditex

General Information


Serial Number98380725
Word MarkARDITEX
Filing DateMonday, January 29, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCollection and systematization of information into computer databases in the medical and clinical fields.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 29, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChina Medical University
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaichung City 406040
TW

Trademark Events


Event DateEvent Description
Monday, January 29, 2024NEW APPLICATION ENTERED
Tuesday, May 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 13, 2024ASSIGNED TO EXAMINER
Monday, June 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 24, 2024NON-FINAL ACTION WRITTEN
Monday, September 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 24, 2024NON-FINAL ACTION E-MAILED